[Molecular targets for colon cancer. VEGF, EGFR - and what else?].

Abstract excerpt

Colorectal cancer (CRC) is the second most common cancer in Germany; there are more than 70,000 new cases annually. It is most commonly a disease of the elderly, and its relative and absolute frequency has risen during the last decades. CRC remains a major clinical and health economy challenge. Progress has been made in patient management and CRC treatment. Screening colonoscopy was introduced in Germany in 2002,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bevacizumab
• Share to Capecitabine
• Share to Colonoscopy